bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2014: D N O S A J J M A M F J
2013: D

 
  Other news for:
Sleep Disorders
 Resources from HONselect
Belsomra Approved for Insomnia
First such drug designed to affect sleep-wake cycle

By Scott Roberts

THURSDAY, Aug. 14, 2014 (HealthDay News) -- Belsomra (suvorexant) has been approved by the U.S. Food and Drug Administration to treat insomnia.

It's among a new class of drugs called orexin receptor antagonists that target orexins, brain chemicals that regulate the body's sleep-wake cycle.

Belsomra should be taken once nightly within 30 minutes of going to bed, the FDA said Wednesday in a news release. Approved in four strengths ranging from 5 milligrams to 20 milligrams, Belsomra should be taken at the lowest effective dose to minimize daytime sleepiness and related side effects, the agency said.

In clinical studies involving more than 500 participants, the drug's most common side effect was next-day drowsiness.

As a condition of approval, New Jersey-based drug maker Merck, Sharpe & Dohme is required to study next-day driving performance among men and women who took the 20-milligram dose, the FDA said.

As with other sleep medicines, the agency warned that users of Belsomra have the potential for sleep-driving, preparing and eating food, making phone calls or having sex while not fully awake. The risk of these and similar "complex behaviors" increases if the user simultaneously drinks alcohol or takes other medicines that make them sleepy, the FDA said.

"Belsomra is a controlled substance [Schedule-IV] because it can be abused or lead to dependence," the agency added.

More information

The FDA has more about this approval.

Copyright © 2014 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=690759

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Sleep Initiation and Maintenance Disorders
Sleep
Brain
Affect
Lead
Sleep Stages
Sleep Disorders
Specialty Chemicals and Products
Beds
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact